These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
593 related items for PubMed ID: 22373847
1. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation]. Kleine-Tebbe J, Ackermann-Simon J, Hanf G. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847 [Abstract] [Full Text] [Related]
6. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885 [Abstract] [Full Text] [Related]
8. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Pokladnikova J, Krcmova I, Vlcek J. Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082 [Abstract] [Full Text] [Related]
9. A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety. Vance GH, Goldring S, Warner JO, Cox H, Sihra B, Hughes S, Gardner J, North J, Roberts G, Proudfoot CA, Clarke A, Luyt DK, Gillies D, Fox AT. Clin Exp Allergy; 2011 Sep; 41(9):1313-23. PubMed ID: 21762222 [Abstract] [Full Text] [Related]
10. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. Hesse L, Brouwer U, Petersen AH, Gras R, Bosman L, Brimnes J, Oude Elberink JNG, van Oosterhout AJM, Nawijn MC. Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757 [Abstract] [Full Text] [Related]
11. A bright future for sublingual immunotherapy--contra. Kleine-Tebbe J. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006 Aug; (95):242-50; discussion 250-2. PubMed ID: 17393746 [Abstract] [Full Text] [Related]
13. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D. Vaccine; 2007 Jan 15; 25(5):957-64. PubMed ID: 17045368 [Abstract] [Full Text] [Related]
14. New applications for sublingual immunotherapy in allergy. Incorvaia C, Mauro M, Cappelletti T, Pravettoni C, Leo G, Riario-Sforza GG. Recent Pat Inflamm Allergy Drug Discov; 2009 Jun 15; 3(2):113-7. PubMed ID: 19519587 [Abstract] [Full Text] [Related]
15. Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy. Schulten V, Tripple V, Aasbjerg K, Backer V, Lund G, Würtzen PA, Sette A, Peters B. Clin Exp Allergy; 2016 Mar 15; 46(3):439-48. PubMed ID: 26436865 [Abstract] [Full Text] [Related]
16. Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real. Reider N. Int Arch Allergy Immunol; 2005 Jul 15; 137(3):181-6. PubMed ID: 15947473 [Abstract] [Full Text] [Related]
19. Specific immunotherapy in children. Bufe A, Roberts G. Clin Exp Allergy; 2011 Sep 15; 41(9):1256-62. PubMed ID: 21518041 [Abstract] [Full Text] [Related]